Clinical Trials Browser

Recruiting × INDUSTRY × Pulmonary Fibrosis × Clear all

NCT06528418 2025-03-26

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Pulmonary Arterial Hypertension, Asthma, Bronchiectasis, Bronchitis, Cystic Fibrosis, Emphysema, Lung Abscess, Lung Diseases, Lung Neoplasms, Pulmonary Embolism, Pulmonary Fibrosis, Tuberculosis, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Lung Injury